Advances in Metabolomics (Technical Insights)
| Publication Date | March 2008 |
|---|---|
| Publisher | Frost & Sullivan |
| Product Type | Report |
| Pages | |
| ISBN Number | not applicable |
| Product Code | FRS00646 |
Buy this product or for assistance call +44 20 7060 7474
Summary
This research service analyzes the global trends in the metabolomics with a focus on the current and prospective applications of this platform.
Content
- Executive summary
- Scope and methodology
- Scope and segmentation of the research service
- Research methodology
- Overview of metabolomics
- The road to metabolomics
- Technology platform for metabolomics
- Applications of metabolomics
- Scope and methodology
- Assessment of enabling technologies--metabolomics
- Noteworthy innovations in companies and universities
- Tracer-based metabolomics platform
- Biospectroscopy-based metabolomics
- Chenomx nmr suite for analysis of nmr spectra
- Pathway studio software for data analysis
- Metabolomics--technology improvements
- Software implemented to manage data in metabolomics studies
- Integrated metabolomics platform aids in biomarker discovery
- Mass spectrometry for omics studies
- The knowitall informatics system for metabolic studies
- Autonano system for mass spectrometry analysis
- Nmr chip for remote detection of nmr
- Drivers and challenges
- Drivers
- Challenges
- Noteworthy innovations in companies and universities
- Assessment of metabolomics applications
- Noteworthy innovations in companies and universities
- Researchers hone in on metabolites to predict drug efficiency
- Metabolomic biomarker discovery platform
- Highly integrated state-of-the-art nmr spectrometer for academic and industry applications
- Metabolic profiling to determine human embryo viability
- Stem cells and metabolomics--new avenues in biomarker discovery
- Application-oriented version of hplc
- Oxidative stress markers in cardiovascular diseases
- Drivers and challenges
- Drivers
- Challenges
- Noteworthy innovations in companies and universities
- Strategic evaluation of the competitive environment
- Ahp--prioritization of metabolomics technologies--criteria
- Definition of criteria
- Snapshot of assessment criteria used for evaluation
- Ahp--prioritization of metabolomics technologies--computation and analyst insights
- Ahp process and computation for goal node and level 0 criteria
- Ahp process and computation for goal node and level 1 criteria
- Final priorities and analyst insights
- Ahp--prioritization of metabolomics technologies--criteria
- Patents and database of key industry participants
- Patents
- Industry patents
- Academic patents
- Key participants
- Companies
- Universities
- Patents
- Decision support database
- Database tables
- Global r&d investment for biotechnology (2002 to 2012)
- Percent government r&d investment in biotechnology (2002 to 2012)
- Global pharmaceutical r&d expenditure (2002 to 2012)
- Global percentage pharmaceutical r&d expenditure (2002 to 2012)
- Database tables
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories











